Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study

Appl Immunohistochem Mol Morphol. 2009 Jan;17(1):12-7. doi: 10.1097/PAI.0b013e318173e79d.

Abstract

Background: Differentiating oncocytoma from its renal cell carcinoma (RCC) mimics, particularly chromophobe RCC, can be difficult, especially when limited tissue is available for evaluation. This study presents a panel of markers that are readily available, easy to use, and useful for differential diagnoses of renal tumors.

Design: A renal cell neoplasm tissue microarray was constructed including oncocytoma (n=30), chromophobe RCC (n=18), conventional RCC (n=64), papillary RCC (n=50), and benign renal tissues (n=31). CK7, CD10, epithelial membrane antigen, renal cell carcinoma marker (RCCma), vimentin, and endogenous avidin-binding activity (EABA) were studied. An Automated Cellular Imaging System, was used to quantify the staining intensity.

Result: EABA was positive in 97% of oncocytoma, 26% of conventional RCC and 35% of papillary RCC with granular/eosinophilic (G/E) features and 6% of chromophobe RCC. EABA was negative in RCC without G/E features. Vimentin and RCCma were positive in most RCC with G/E features (conventional, 78% and 71%; and papillary, 85% and 76%, respectively), and negative in oncocytoma. Vimentin was also negative in chromophobe RCC. CK7 was positive in up to 81% of papillary RCC and 63% of chromophobe RCC, and essentially negative in conventional RCC and oncocytoma.

Conclusions: EABA is an excellent marker for oncocytoma, which can be useful in differentiating oncocytoma from chromophobe RCC. A panel of EABA, vimentin, and RCCma markers can be useful in discerning oncocytoma from RCC with G/E features. Vimentin can be useful in discriminating chromophobe RCC from papillary or conventional RCCs.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma, Oxyphilic / diagnosis*
  • Antigens, Neoplasm / analysis
  • Automation
  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / standards
  • Carcinoma, Renal Cell / diagnosis
  • Diagnosis, Differential
  • Humans
  • Mitogen-Activated Protein Kinases / analysis
  • Sensitivity and Specificity
  • Tissue Array Analysis / methods*
  • Tissue Array Analysis / standards*
  • Vimentin / analysis

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Vimentin
  • MOK protein, human
  • Mitogen-Activated Protein Kinases